YOU ARE HERE: LAT HomeCollectionsInfections


August 15, 1996 | From Times staff and wire reports
Confirming generations of popular wisdom, a major study has found that frequent sexual intercourse and spermicides increase the risk of urinary tract infections in women. The research also estimates that such infections occur in sexually active young women about once every two years. The study found that the more frequently young women have intercourse, the more likely they are to get the infections.
Dillon White's first ear infection arrived at the tender age of 6 months. And what followed is an all-too-familiar story in many families: repeated earaches. By age 2, Dillon had surgery to insert tubes in his ears to drain fluid and reduce the breeding ground for infections. "I was in the medical office building every month from age 6 months on getting antibiotics," said Dillon's mother, Gayle White. "I did not want him to have surgery. But we had tried everything else."
May 21, 1990 | Times science writer Thomas H. Maugh II reports from the annual meeting of the American Society for Microbiology held last week in Anaheim. and
Use of nonoxynol-9, the active component in many spermicidal creams and foams, increases the risk of recurrent cystitis and yeast infections in women, according to Dr. Jackie McGroarty of Toronto General Hospital. Tests in the laboratory, she said, show that nonoxynol-9 serves as a nutrient that promotes the growth of the Eschericia coli bacteria that cause cystitis, as well as Candida albicans, the yeast responsible for vaginal infections.
August 13, 1990 | From Times staff and wire reports
A combination of antibiotics taken after intercourse appears to be highly effective in preventing urinary tract infections among women prone to such disorders, researchers reported last week. The drugs involved are commonly sold under the trade names Bactrim and Septra. Researchers at the University of Washington in Seattle said they tested a group of women who had suffered at least two urinary tract infections in the preceding year.
January 4, 2001
Most hospital Staphylococcus aureus infections--best known for causing toxic shock syndrome--are caused when bacteria lodged in the noses of patients spread out of control, according to a study by German scientists in today's New England Journal of Medicine.
November 8, 2004 | From the Hartford Courant
Contrary to popular belief, most brain damage in premature babies is caused by infections, not a lack of oxygen, researchers at Johns Hopkins University say. "To reduce the risk of brain injury in the premature neonate, physicians may have to pay more attention to infections that occur around the time of birth," said Dr. Ernest Graham, assistant professor of medicine and author of the study that appeared in the October online edition of the American Journal of Obstetrics and Gynecology.
June 27, 1993 | Associated Press
A man who contracted the AIDS virus from Florida dentist David J. Acer died Saturday of complications from the disease. He was 33. Richard Driskill died of pancreatic failure, said his lawyer Robert Montgomery. Driskill was one of six patients known to have been infected by Acer, who died in 1990.
November 26, 2003 | Rosie Mestel, Times Staff Writer
The global spread of AIDS shows no sign of slackening, with an estimated 3 million deaths this year, according to the United Nations' annual report on the epidemic released Tuesday. The report found the number of new HIV infections in 2003 totaled 5 million, or about 14,000 people a day -- the highest number ever. One in five adults in southern Africa is infected with the virus.
A 35-year-old Santa Barbara triathlete stricken with a rare and virulent streptococcus infection that has become notorious as "flesh-eating" bacteria was improved Thursday afternoon, but remained in critical condition at Sherman Oaks Hospital's burn center. The infection is the same type that set off alarming news reports when a cluster of seven cases was reported in Gloucestershire, England, this spring, followed by a number of reports in the United States.
September 3, 1987 | HARRY NELSON, Times Medical Writer
A genetically engineered hormone with the potential for revolutionizing the treatment of infections has passed its first human safety trial, UCLA and Harvard medical scientists said in a report published today. In experiments conducted in Los Angeles and Boston, the hormone was given to 16 AIDS patients suffering from a wide variety of viral, bacterial and fungal infections that typically afflict people with acquired immune deficiency syndrome.
Los Angeles Times Articles